mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.01 |
mRNA |
Axitinib |
GDSC1000 |
pan-cancer |
AAC |
0.091 |
0.01 |
mRNA |
ABT-888 |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.01 |
mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.14 |
0.01 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.01 |
mRNA |
RG-108 |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.01 |
mRNA |
KW-2449 |
CTRPv2 |
pan-cancer |
AAC |
0.076 |
0.01 |
mRNA |
BRD-K75293299 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
0.01 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.01 |
mRNA |
IPR-456 |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.01 |